Search clinical trials for: Acutely inflammed gall bladder
Total 9187 results
-
Baylor College of MedicineLawson Health Research Institute; Chr HansenUnknown
-
Royal Brompton & Harefield NHS Foundation TrustGlaxoSmithKline; Uppsala UniversityUnknownAcute Coronary SyndromeSpain, United Kingdom, France, Italy, Poland
-
Nantes University HospitalCompletedUrinary Tract InfectionFrance
-
University College London HospitalsUnknown
-
University of AarhusCompletedOveractive Bladder | Urinary IncontinenceDenmark
-
University of AarhusCompletedOveractive Bladder | Urinary IncontinenceDenmark
-
University Of PerugiaCompleted
-
University of L'AquilaCompletedOveractive Bladder | Detrusor UnderactivityItaly
-
Oslo University HospitalUniversity of OsloUnknown
-
Cantonal Hospital of St. GallenUniversity of ZurichUnknownIneffective Motility | Diffuse Esophageal Spasms | Achalasia-Like DysmotilitySwitzerland
-
Taiwan Otsuka Pharm. Co., LtdCompletedSchizophrenia | Schizoaffective DisorderTaiwan
-
Federal University of São PauloUnknown
-
Technische Universität DresdenCompleted
-
Catholic University of the Sacred HeartCompleted
-
University Of PerugiaTerminated
-
PfizerCompletedOveractive Bladder SyndromeGermany
-
US Department of Veterans AffairsCompleted
-
Lawson Health Research InstituteTerminated
-
Istituto Superiore di SanitàCompletedClassical Kaposi's SarcomaItaly
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina
-
PfizerCompleted
-
Millennium Pharmaceuticals, Inc.TerminatedBreast Neoplasm | Pancreatic Neoplasm | Colon Neoplasm | Bladder NeoplasmUnited States
-
Università degli Studi dell'InsubriaCompletedOveractive BladderItaly
-
PfizerCompleted
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, France, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Spain, United Kingdom, Vietnam, Germany, Philippines, Malaysia, Sweden, Estonia, Latvia, Lithuania, Finland, Norway and more
-
Sheba Medical CenterUnknown
-
AstraZenecaTerminatedType 2 DiabetesCzech Republic, France, Poland, Philippines, Estonia, Latvia, Lithuania, Norway, Hungary, Slovakia, Greece, Sweden, Australia, Former Serbia and Montenegro
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, Italy, Korea, Republic of, Russian Federation, South Africa, United Kingdom, Vietnam, Philippines, Malaysia, Estonia, Latvia, Lithuania, Poland, Finland, Canada, Hong Kong, Argentina, Hun... and more
-
Fujirebio Diagnostics, Inc.Completed
-
National Human Genome Research Institute (NHGRI)Completed
-
National Cancer Institute (NCI)CompletedCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States
-
National Cancer Institute (NCI)Completed
-
Avera PharmaceuticalsTerminatedOveractive Bladder SyndromeNetherlands, United Kingdom
-
Atrium Medical CenterMaastricht UniversityUnknown
-
North Bristol NHS TrustTerminatedCholedocholithiasis | Higher Risk Patients
-
Sterling HospitalCompletedCholelithiasisIndia
-
National Taiwan University HospitalTerminated
-
Tabriz UniversityUnknownNeurogenic Bladder
-
APOGEPHA Arzneimittel GmbHCompletedOveractive Bladder | Urinary Incontinence | Children
-
NovartisProcter and GambleCompletedUrinary IncontinenceUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
NovartisProcter and GambleCompletedOveractive Bladder (OAB)United States
-
TelikCompletedStudy of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNon Small Cell Lung CarcinomaUnited States, Australia, Brazil, Chile, Germany, Argentina, Italy, United Kingdom
-
NovartisProcter and GambleCompleted
-
Hebrew University of JerusalemAnchiano Therapeutics Israel Ltd.Completed
-
University Hospital, GhentCompletedMicturition DisorderBelgium